Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 6, 1997, Pages 2057-2063

  Ohno, Hideaki ^a   Koga, Hironobu ^b   Kuroita, Toshihiro ^b   Tomono, Kazunori ^b   Ogawa, Kazuhiko ^b   Yanagihara, Katsunori ^b   Yamamoto, Yoshihiro ^b   Miyamoto, Junko ^b   Tashiro, Takayoshi ^b   Kohno, Shigeru ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUBERCULOSIS;

EID: 8244253680     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.6.9196115     Document Type: Article

References (29)

1. British Thoracic Association. 1982. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Am. Rev. Respir. Dis. 126:460-462.
2. Mitchison, D. A., and A. J. Nunn. 1986. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am. Rev. Respir. Dis. 133:423-430.
3. American Thoracic Society. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1359-1374.
4. Edlin, B. R., J. I. Tokars, M. H. Grieco, J. T. Crawford, J. Williams, E. M. Sordillo, K. R. Ong, J. O. Kilburn, S. W. Dooley, K. G. Castro, W. R. Jarvis, and S. D. Holmberg. 1992. An outbreak of multidrug resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 326:1514-1521.
5. Frieden, T. R., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-426.
6. Nolan, C. M., D. L. Williams, M. D. Cave, K. D. Eisenach, H. El-Hajj, T. M. Hooton, R. L. Thompson, and S. V. Goldberg. 1995. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am. J. Respir. Crit. Care Med. 152:1067-1071.
7. Lutfey, M., P. Della-Latta, V. Kapur, L. A. Palumbo, D. Gurner, G. Stotzky, K. Brudney, J. Dobkin, A. Moss, J. M. Musser, and B. N. Kreiswirth. 1996. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am. J. Respir. Crit. Care Med. 153: 837-840.
8. H. Bishai, W. R., N. M. H. Graham, S. Harrington, C. Page, K., Moore-Rice, N. Hooper, and R. E. Chaisson. 1996. Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. N. Engl. J. Med. 334:1573-1576.
9. Tuberculosis Research Committee. 1992. Primary drug resistance to the major anti-tuberculosis drugs in Japan in 1992. Tuberculosis Research Committee. Tokyo, Japan. (In Japanese)
10. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopper, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341: 647-650.
11. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
12. Banerjee, A., E. Dubnau, A. Quemard, V. Balausubramanian, K. Sun Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
13. Honore, N., and S. Cole. 1994. Streptomycin resistance in mycobacteria. Antimicrob. Agents Chemother. 38:238-242.
14. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
15. Miller, L. P., J. Crawford, and T. M. Shinnick. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
16. Kapur, V., L.-L. Li, S. Iordanescu, M. R. Hamrick, A. Wanger, B. N. Kreiswirth, and J. M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase ß subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32: 1095-1098.
17. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampicin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
18. Felmlee, T. A., Q. Liu, A. C. Whelen, D. Williams, S. S. Sommer, and D. H. Persing. 1995. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J. Clin. Microbiol. 33:1617-1623.
19. Ohno, H., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40: 1053-1056.
20. Wallace, R. J., Jr., D. R. Nash, L. C. Steele, and V. Steingrube. 1986. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clin. Microbiol. 24:976-981.
21. Inderlied, C. B., 1991. Antimycobacterial agents: in vitro susceptibility testing, spectrums of activity, mechanisms of action and resistance, and assays for activity in biological fluids. In V. Lorian, editor. Antibiotics in Laboratory Medicine. Williams & Wilkins, Baltimore. 134-149.
22. Miyazaki, Y., H. Koga, S. Kohno, and M. Kaku. 1993. Nested polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. J. Clin. Microbiol. 31:2228-2232.
23. Sjobring, U., M. Mecklenburg, A. S. Andersen, and H. Miorner. 1990. Polymerase chain reaction for detection of Mycobacterium tuberculosis. J. Clin. Microbiol. 28:2200-2204.
24. Cole, S. T., and A. Telenti. 1995. Drug resistance in Mycobaclerium tuberculosis. Eur. Respir. J. 20(Suppl.):701s-713s.
25. Bodmer, T., G. Zurcher, P. Imboden, and A. Telenti. 1995. Mutation position and type of substitution in the ß-subunit of the RNA polymerase influence in vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 35:345-348.
26. Yamada, T., A. Nagata, Y. Ono, Y. Suzuki, and T. Yamanouchi. 1985. Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 27:921-924.
27. Hashimoto, A., H. Koga, S. Kohno, Y. Miyazaki, M. Kaku, and K. Hara. 1996. Rapid detection and identification of mycobacteria by combined method of polymerase chain reaction and hybridization protection assay. J. Infect. 33:71-77.
28. Hui, J., N. Gordon, and R. Kajioka. 1977. Permeability barrier to rifampin in mycobacteria. Antimicrob. Agents Chemother. 11:773-779.
29. Guerrero, G., L. Stockman, F. Marchesi, T. Bodmer, G. Roberts, and A. Telenti. 1994. Evaluation of the rpoB gene in rifampicin-susceptible and resistant Mycobacterium avium and M. intracellulare. J. Antimicrob. Chemother. 33:661-663.